Health Care

Aetna Exits Iowa Individual Insurance Market for 2018

Aetna Inc will exit Iowa's Obamacare-compliant individual insurance market in 2018, a year surrounded by uncertainty over which insurers will sell plans and at what price as Republicans seek to dismantle the 2010 Affordable Care Act.

U.S. FDA Allows 23andMe to Sell Genetic Tests for 10 Diseases

The U.S. Food and Drug Administration on Thursday agreed to allow genetic testing company 23andMe to market tests directly to consumers to assess their predisposition to develop 10 diseases, including Parkinson's, Alzheimer's and Celiac disease.

New Cancer Drugs Show Success at a Steep Price

Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year.